Literature DB >> 28226336

Educational Outreach to Opioid Prescribers: The Case for Academic Detailing.

Margot Trotter Davis1, Brian Bateman2, Jerry Avorn3.   

Abstract

Nonmedical use of opioid medications constitutes a serious health threat as the rates of addiction, overdoses, and deaths have risen in recent years. Increasingly, inappropriate and excessively liberal prescribing of opioids by physicians is understood to be a central part of the crisis. Public health officials, hospital systems, and legislators are developing programs and regulations to address the problem in sustained and systematic ways that both insures effective treatment of pain and appropriate limits on the availability of opioids. Three approaches have obtained prominence as means of avoiding excessive and inappropriate prescribing, including: providing financial incentives to physicians to change their clinical decision through pay-for-performance contracts, monitoring patient medications through Prescription Drug Monitoring Programs, and educational outreach to physicians. A promising approach to educational outreach to physicians is an intervention known as "academic detailing." It was developed in the 1980s to provide one-on-one educational outreach to physicians using similar methods as the pharmaceutical industry that sends "detailers" to market their products to physician practices. Core to academic detailing, however, is the idea that medical decisions should be based on evidence-based information, including managing conditions with updated assessment measures, behavioral, and nonpharmacological interventions. With the pharmaceutical industry spending billions of dollars to advertise their products, individual practitioners can have difficulty gathering unbiased information, especially as the number of approved medications grows each year. Academic detailing has successfully affected the management of health conditions, such as atrial fibrillation, chronic obstructive pulmonary disease, and recently, has targeted physicians who prescribe opioids. This article discusses the approach as a potentially effective preventative intervention to address the epidemic of opioid overuse.Key words: Opioid abuse, opioid misuse, academic detailing, health policy, interactive education,prevention.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28226336

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  11 in total

1.  Where Is the Opioid Use Epidemic in Mexico? A Cautionary Tale for Policymakers South of the US-Mexico Border.

Authors:  David Goodman-Meza; Maria Elena Medina-Mora; Carlos Magis-Rodríguez; Raphael J Landovitz; Steve Shoptaw; Dan Werb
Journal:  Am J Public Health       Date:  2018-11-29       Impact factor: 9.308

2.  Capsule Commentary on Magin et al., Changes in Australian Early-Career General Practitioners' Benzodiazepine Prescribing: a Longitudinal Analysis.

Authors:  Benjamin J Oldfield
Journal:  J Gen Intern Med       Date:  2018-10       Impact factor: 5.128

3.  Variation in post-discharge opioid prescriptions among members of a surgical team.

Authors:  Eddie Blay; Michael J Nooromid; Karl Y Bilimoria; Jane L Holl; Bruce Lambert; Julie K Johnson; Jonah J Stulberg
Journal:  Am J Surg       Date:  2017-11-01       Impact factor: 2.565

4.  U.S. Re-Licensure Opioid/Pain Management Continuing Education Requirements in Dentistry, Dental Hygiene, and Medicine.

Authors:  R Constance Wiener; Christopher Waters; Ruchi Bhandari; Alcinda K Trickett Shockey; Fotinos Panagakos
Journal:  J Dent Educ       Date:  2019-06-10       Impact factor: 2.264

5.  Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV.

Authors:  Benjamin J Oldfield; Kathleen A McGinnis; E Jennifer Edelman; Emily C Williams; Adam J Gordon; Kathleen Akgün; Stephen Crystal; Lynn E Fiellin; Julie R Gaither; Joseph L Goulet; P Todd Korthuis; Brandon D L Marshall; Amy C Justice; Kendall Bryant; David A Fiellin; Kevin L Kraemer
Journal:  J Subst Abuse Treat       Date:  2019-11-06

6.  Identifying opioid prescribing patterns for high-volume prescribers via cluster analysis.

Authors:  Nisha Nataraj; Kun Zhang; Gery P Guy; Jan L Losby
Journal:  Drug Alcohol Depend       Date:  2019-02-16       Impact factor: 4.492

7.  A statewide effort to reduce high-dose opioid prescribing through coordinated care organizations.

Authors:  Daniel M Hartung; Lindsey Alley; Gillian Leichtling; P Todd Korthuis; Christi Hildebran
Journal:  Addict Behav       Date:  2018-05-01       Impact factor: 3.913

8.  Program development and implementation outcomes of a statewide addiction consultation service: Maryland Addiction Consultation Service (MACS).

Authors:  Sarah Sweeney; Kelly Coble; Elizabeth Connors; Kathleen Rebbert-Franklin; Christopher Welsh; Eric Weintraub
Journal:  Subst Abus       Date:  2020-08-19       Impact factor: 3.716

9.  Comparison of Rural vs Urban Direct-to-Physician Commercial Promotion of Medications for Treating Opioid Use Disorder.

Authors:  Thuy Nguyen; Barbara Andraka-Christou; Kosali Simon; W David Bradford
Journal:  JAMA Netw Open       Date:  2019-12-02

Review 10.  Misalignment of Stakeholder Incentives in the Opioid Crisis.

Authors:  Alireza Boloori; Bengt B Arnetz; Frederi Viens; Taps Maiti; Judith E Arnetz
Journal:  Int J Environ Res Public Health       Date:  2020-10-16       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.